The cost-sharing burden of high-deductible health plans may delay breast cancer diagnosis, according to researchers.

Diagnostic performance comparable for two test sets from the Personal Performance in Mammographic Screening scheme.

Ovarian function suppression improved disease-free survival in patients with ER+ breast cancer who were premenopausal or resumed ovarian function after chemotherapy.

Combination model achieved higher AUC for interval and long-term cancers grouped together.

Omitting radiotherapy after breast-conserving surgery is safe for certain patients with breast cancer, according to researchers.

Withholding chemotherapy in first-line treatment does not compromise overall survival in HER2+ advanced breast cancer, according to researchers.

Black and White women with metastatic breast cancer may experience different outcomes based on level of neighborhood deprivation.

Multiple risk factors and impacts were noted in a review examining financial toxicity in patients with breast cancer.

Significantly higher 10-year net survival seen for women aged 40 to 49 years with screening programs that include women in their 40s.

Estimated 31 percent of breast cancers overdiagnosed among screened women aged 70 to 74 years.